Moving towards a daratumumab standard of care in MM
OPTIMISMM: benefits of a new triplet therapy for MM patients relapsing on lenalidomide
Imaging modalities and treatment breakthroughs in myeloma bone disease
Cereblon pathway-mediated IMiD resistance in multiple myeloma
Anti-BCMA CAR T-cells in myeloma: what data do we have so far?